Development of immunomodulatory six base-length non-CpG motif oligonucleotides for cancer vaccination (Q47356200)

14 January 2018

title

Development of immunomodulatory six base-length non-CpG motif oligonucleotides for cancer vaccination (English)

1 reference

14 January 2018

author name string

Mario C Filion

1

1 reference

14 January 2018

Benoit Filion

2

1 reference

14 January 2018

Julie Roy

3

1 reference

14 January 2018

Sonia Ménard

4

1 reference

14 January 2018

Stéphanie Reader

5

1 reference

14 January 2018

Nigel C Phillips

6

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 June 2004

1 reference

14 January 2018

published in

Vaccine

1 reference

14 January 2018

volume

22

1 reference

14 January 2018

issue

19

1 reference

14 January 2018

page(s)

2480-2488

1 reference

14 January 2018

Development of short non-CpG phosphodiester oligonucleotides as immune stimulatory agents.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

IL-12: a promising adjuvant for cancer vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Aspirin induces apoptosis through mitochondrial cytochrome c release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Phosphatidylserine-mediated phagocytosis of anticancer drug-treated cells by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Release of apoptogenic proteins from the mitochondrial intermembrane space during the mitochondrial permeability transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Cleavage of the nuclear matrix protein NuMA during apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

CTL-defined cancer vaccines: perspectives for active immunotherapeutic interventions in minimal residual disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

CD95 ligand expression as a mechanism of immune escape in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Current concepts in cancer vaccine strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Immunotherapy of cancer with dendritic-cell-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

CpG oligodeoxynucleotides enhance monoclonal antibody therapy of a murine lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

How tumors escape immune destruction and what we can do about it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Effect of immunostimulatory CpG-oligonucleotides in chronic lymphocytic leukemia B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

CpG oligodeoxynucleotides rescue BKS-2 immature B cell lymphoma from anti-IgM-mediated growth inhibition by up-regulation of egr-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Interplay between the toxic effects of anticancer drugs and host antitumor immunity in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

Tumor-induced immune dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.072

10.1016/J.VACCINE.2003.11.072

7 January 2021

Identifiers

DOI

1 reference

14 January 2018

release_n4ufsg7fkbehhc43k25p6achti

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n4ufsg7fkbehhc43k25p6achti

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15193412

1 reference

14 January 2018